Mitobridge is Drug Discovery in United States that focus on molecule therapeutics business. Founded in 2011. They cover business area such as developer, small molecule therapeutic, mitochondrial function, mitochondria function, treatment, genetic, metabolic and neurodegenerative disorder, aging, patient, a high likelihood.
2011
( 13 years old in 2024 )
Molecule Therapeutics
-
1030 Massachusetts Avenue
Suite 200
Cambridge, MA 02138
United States
Private
developersmall molecule therapeuticmitochondrial functionmitochondria functiontreatmentgenetic, metabolic and neurodegenerative disorderagingpatienta high likelihood
* We use standard office opening hours in near Mitobridge's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Mitobridge is Drug Discovery business from United States that founded in 2011 (13 years old in 2024), Mitobridge business is focusing on Molecule Therapeutics.
Mitobridge headquarter office and corporate office address is located in 1030 Massachusetts Avenue Suite 200 Cambridge, MA 02138 United States.
Mitobridge was founded in United States.
In 2024, Mitobridge is currently focus on molecule therapeutics sector.
Above is snippet of Google Trends for "molecule therapeutics" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Mitobridge, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
